PET using new agent is better for CAD diagnosis than SPECT:

06/10/2010 | HealthImaging.com

PET using the experimental agent BMS747158 yielded better images than technetium-99m sestamibi SPECT in the diagnosis of coronary artery disease, a Phase II study showed. The PET method also pinpointed a bigger perfusion defect area than identified by SPECT imaging, according to the study.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Director, Site Quality Management
CareFusion
Palm Springs, CA